A method comparison of total and HMW adiponectin: HMW/total adiponectin ratio varies versus total adiponectin, independent of clinical condition

Clinica Chimica Acta

Volumn 465, Issue , 2017, Pages 30-33

  van Andel, Merel ^a   Drent, Madeleine L ^a,b   van Herwaarden, Antonius E ^c   Ackermans, Mariëtte T ^d   Heijboer, Annemieke C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adiponectin isoforms; Cardiovascular disease; High molecular weight total adiponectin ratio; Method comparison; Patient characteristics

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; ISOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CHEMILUMINESCENCE IMMUNOASSAY; CHEMILUMINESCENCE IMMUNOASSAY KIT; CHILD; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RADIOIMMUNOASSAY KIT; BLOOD; COMPARATIVE STUDY; DIALYSIS; ENZYME IMMUNOASSAY; LUMINESCENCE; METABOLISM; MIDDLE AGED; MOLECULAR WEIGHT; PROCEDURES;

ADIPONECTIN; ADOLESCENT; BODY MASS INDEX; CHILD; DIALYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; LUMINESCENT MEASUREMENTS; MIDDLE AGED; MOLECULAR WEIGHT; PROTEIN ISOFORMS; RADIOIMMUNOASSAY;

EID: 85006166031     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.12.009     Document Type: Article

References (33)

1. [1] Waki, H., Yamauchi, T., Kamon, J., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278 (2003), 40352–40363.
2. [2] Saisho, Y., Hirose, H., Roberts, R., Abe, T., Kawabe, H., Itoh, H., C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study. PLoS One, 8, 2013, e73430.
3. [3] Almeda-Valdes, P., Cuevas-Ramos, D., Mehta, R., et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc. Diabetol., 9(26), 2010.
4. [4] Heidemann, C., Sun, Q., van Dam, R.M., et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med. 149 (2008), 307–316.
5. [5] Miyazaki, T., Hiki, M., Shimada, K., et al. The high molecular weight adiponectin level is associated with the atherogenic lipoprotein profiles in healthy Japanese males. J. Atheroscler. Thromb. 21 (2014), 672–679.
6. [6] Kunita, E., Yamamoto, H., Kitagawa, T., et al. Association between plasma high-molecular-weight adiponectin and coronary plaque characteristics assessed by computed tomography angiography in conditions of visceral adipose accumulation. Circ. J. 76 (2012), 1687–1696.
7. [7] Tsutamoto, T., Tanaka, T., Sakai, H., et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur. Heart J. 28 (2007), 1723–1730.
8. [8] Choi, S.H., EJ, K., Hong, E.S., et al. High serum adiponectin concentration and low body mass index are significantly associated with increased all-cause and cardiovascular mortality in an elderly cohort, “adiponectin paradox”: the Korean Longitudinal Study on Health and Aging (KLoSHA). Int. J. Cardiol. 183 (2015), 91–97.
9. [9] Menzaghi, C., Xu, M., Salvemini, L., et al. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovasc. Diabetol., 13(130), 2014.
10. [10] Ortega Moreno, L., Lamacchia, O., Fontana, A., et al. The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: evidence of synergism with abdominal adiposity. Atherosclerosis 250 (2016), 23–29.
11. [11] Zoccali, C., Mallamaci, F., Tripepi, G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J. Am. Soc. Nephrol. 13 (2002), 134–141.
12. [12] Komaba, H., Igaki, N., Goto, S., et al. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am. J. Nephrol. 26 (2006), 476–482.
13. [13] Bueno, A.C., Sun, K., Martins, C.S., et al. A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome. J. Clin. Endocrinol. Metab. 99 (2014), E683–E693.
14. [14] Menzaghi, C., Salvemini, L., Paroni, G., et al. Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. J. Intern. Med. 267 (2010), 287–294.
15. [15] Bobbert, T., Rochlitz, H., Wegewitz, U., et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54 (2005), 2712–2719.
16. [16] Christiansen, T., Paulsen, S.K., Bruun, J.M., Ploug, T., Pedersen, S.B., Richelsen, B., Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J. Clin. Endocrinol. Metab. 95 (2010), 911–919.
17. [17] Fargnoli, J.L., Fung, T.T., Olenczuk, D.M., Chamberland, J.P., FB, H., Mantzoros, C.S., Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses’ Health Study. Am. J. Clin. Nutr. 88 (2008), 1213–1224.
18. [18] Garekani, E.T., Mohebbi, H., Kraemer, R.R., Fathi, R., Exercise training intensity/volume affects plasma and tissue adiponectin concentrations in the male rat. Peptides 32 (2011), 1008–1012.
19. [19] Ruth, M.R., Port, A.M., Shah, M., et al. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism 62 (2013), 1779–1787.
20. [20] Hajri, T., Tao, H., Wattacheril, J., Marks-Shulman, P., Abumrad, N.N., Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-alpha and interleukin-6. Am. J. Physiol. Endocrinol. Metab. 300 (2011), E350–E360.
21. [21] Rose, F.J., Webster, J., Barry, J.B., Phillips, L.K., Richards, A.A., Whitehead, J.P., Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes. Diabetes Obes. Metab. 12 (2010), 1084–1089.
22. [22] Ibanez, L., Lopez-Bermejo, A., Diaz, M., Jaramillo, A., Marin, S., de Zegher, F., Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. J. Clin. Endocrinol. Metab. 95 (2010), 2234–2239.
23. [23] Nacci, C., Leo, V., De Benedictis, L., et al. Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity. J. Clin. Endocrinol. Metab. 98 (2013), E683–E693.
24. [24] Yarrow, J.F., Beggs, L.A., Conover, C.F., McCoy, S.C., Beck, D.T., Borst, S.E., Influence of androgens on circulating adiponectin in male and female rodents. PLoS One, 7, 2012, e47315.
25. [25] Caselli, C., Melaiu, O., Maltinti, M., et al. A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays. Clin. Chem. Lab. Med. 48 (2010), 561–568.
26. [26] Ebinuma, H., Miyazaki, O., Yago, H., Hara, K., Yamauchi, T., Kadowaki, T., A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin. Chim. Acta 372 (2006), 47–53.
27. [27] Sinha, M.K., Songer, T., Xiao, Q., et al. Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin. Chem. 53 (2007), 2144–2151.
28. [28] Suominen, P., Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin. Chem. 50 (2004), 219–221.
29. [29] Hayama, S., Higuchi, T., Miyakoshi, H., Nakano, Y., Analytical evaluation of a high-molecular-weight (HMW) adiponectin chemiluminescent enzyme immunoassay. Clin. Chim. Acta 411 (2010), 2073–2078.
30. [30] Tanita, T., Miyakoshi, H., Nakano, Y., Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin. J. Immunol. Methods 333 (2008), 139–146.
31. [31] Hara, K., Horikoshi, M., Yamauchi, T., et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29 (2006), 1357–1362.
32. [32] Aso, Y., Yamamoto, R., Wakabayashi, S., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55 (2006), 1954–1960.
33. [33] Nakano, Y., Tajima, S., Yoshimi, A., et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J. Lipid Res. 47 (2006), 1572–1582.